Search Results
Results found for "Justin English"
- 📰 GPCR Weekly News, June 10 to 16, 2024
Justin English on "Empowering Drug Discovery for the GPCR Community"!
- Unlock the Future of GPCR Science: Breakthroughs and Courses Await | Sep 2 - Sep 8, 2024
receptors could have sweeping implications for drug development DeepCure team is excited to welcome Justin
- FDA Approval Is a Strategy Obstacle, Not a Paperwork Problem
Where’s your dose justification? How consistent is your manufacturing? 5️⃣ Patient targeting rationale: Are you selecting the right patient subgroup with a clear justification label claims , not just scientific curiosity You design preclinical studies that support your dose justification
- Aβ peptides stabilize GPCRs in inactive form and trigger inverse agonism in Alzheimer's disease
This paradox solicits urgent attention to find a suitable justification for disturbed neurotransmission
- Harnessing Deep Mutational Scanning for Enhanced Drug Discovery
D., English, J. G., Coyote-Maestas, W., & Aashish Manglik. (2024).
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
Olsen RHJ, English JG. Olsen RHJ, DiBerto JF, English JG, Glaudin AM, Krumm BE, Slocum ST, et al.
- The Real Cost of Strategic Overload in Biotech
Can the entire strategy be explained through one coherent throughline, or does it require layered justifications
- The Moment Biotech Founders Realize the Money Is Gone
Roadmaps stop being tools for choice and start becoming tools for justification.
- Biotech Startup Failure: Why Teams Drift Off Course Without a Single Wrong Decision
Clear commitments allow progress without constant re-justification. 4️⃣ Regularly examine decisions as
- Why Fundraising Mistakes Kill Strong Biotech Startups
👉 When that question becomes dominant, strategy quietly shifts from intentional design to reactive justification
